Trials / Recruiting
RecruitingNCT06810635
Polyphenol Metabotypes in People With Diabetes Type 2
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 40 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
This cross-sectional study seeks to characterize the overall polyphenol metabotype in patients with T2DM in comparison to age-matched individuals without diabetes. Additionally, the study aims to identify factors that influence the polyphenol metabotype (transit time and gut microbial capacity to degrade polyphenols in particular).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Oral Polyphenol Challenge Test / PPPIL | Patients will receive a so-called oral polyphenol challenge test. It is a pill containing a multitude of polyphenol classes (doi: 10.1093/cdn/nzac072.020) |
| DIAGNOSTIC_TEST | fasting blood sample | Fasting blood sample will be obtained for determination of markers of metabolic health. |
| DIAGNOSTIC_TEST | Fasting urine collection | Subjects collect morning urine (or the urine thereafter ) in a separate urine container and write down the time of urine collection for determination of polyphenol metabolites |
| DIAGNOSTIC_TEST | 24 hours urine collection | Subjects collect urine over the entire 24h. for determination of polyphenol metabolites |
| OTHER | Questionnaires | Questionnaires will be performed to collect information on lifestyle and baseline characteristics: physical activity (IPAQ), sleep (PSQI), drinking and smoking behaviour, drug intake and medical record. |
| DIAGNOSTIC_TEST | Stool collection | Optional: some subjects collect stool samples to test the capacity of the microbiome to degrade polyphenols with a batch experiment. |
| DIAGNOSTIC_TEST | Transit time determination | Subjects take a pill containing 90mg of royal blue dye (E133) together with the polyphenol pill to determine their transit time. When their stool discolours, the subjects notify the researcher. |
Timeline
- Start date
- 2026-03-04
- Primary completion
- 2028-11-01
- Completion
- 2028-12-01
- First posted
- 2025-02-05
- Last updated
- 2026-03-23
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT06810635. Inclusion in this directory is not an endorsement.